GlyCylic

Manufacturer
The Tetra Corporation
Effective date
2025-08-18
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 01:10:57

Label at a glance#

ProductGlyCylic
Active ingredientSALICYLIC ACID
Label structure8 sections

Indications and uses

for the removal of common and plantar warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface. The plantar wart exists only on the bottom of the foot and interrupts footprint pattern.

Dosage and administration

• wash affected area, may soak wart in warm water for 5 minutes • dry area thoroughly • apply small amount of wart remover with applicator to sufficiently cover each wart • let dry and repeat this procedure once or twice daily until wart is removed for up to 12 weeks

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 17%

Purpose

OTC - PURPOSE SECTION

Wart Remover

Uses

INDICATIONS & USAGE SECTION

for the removal of common and plantar warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface. The plantar wart exists only on the bottom of the foot and interrupts footprint pattern.

Warnings

WARNINGS SECTION

FOR EXTERNAL USE ONLY.

Flammable
• keep away from fire or flame.
• cap bottle tightlyand store at room temperature away from heat.

Do not use
• if you are a diabetic or have poor blood circulation, except under the advice and supervision of a doctor or podiatrist.
• irritated, infected or reddened skin.
• genital warts and warts on the face.
• moles, birthmarks and warts with hair growing from them.
• mucous membranes.

When using this product
• avoid contact with eyes. If product gets into the eyes, flush with water for 15 minutes.
• avoid inhaling vapors.

Stop use and ask doctor if
• discomfort persists.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• wash affected area, may soak wart in warm water for 5 minutes

• dry area thoroughly

• apply small amount of wart remover with applicator to sufficiently cover each wart

• let dry and repeat this procedure once or twice daily until wart is removed for up to 12 weeks

Inactive ingredients

INACTIVE INGREDIENT SECTION

Collodion USP, SDA-40-B 200pf, Glycerin USP, Ethoxydiglycol (Transcutol/Carbitol), Glycolic Acid 70%, Ethyl Pyruvate, Povidone/Iodine USP

Product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage descriptionimage descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2604784GlyCylic 17 % Topical GelPSN5
312880salicylic acid 17 % Topical GelPSN5
2604784salicylic acid 0.17 MG/MG Topical Gel [Glycylic]SBD5
312880salicylic acid 0.17 MG/MG Topical GelSCD5
2604784Glycylic 17 % Topical GelSY5
312880salicylic acid 17 % Topical GelSY5

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49406-009-152025-08-18C16284748780-12cef2736-6ea4-d83d-e063-dadaa90ab31f501d3ba9-ba42-4c1c-983b-492adaee039d
49406-009-152025-01-30C16284748780-12cef2736-6ea4-d83d-e063-dadaa90ab31f501d3ba9-ba42-4c1c-983b-492adaee039d

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49406-009-15GlyCylic1 in 1 BOXLIQUID15
49406-009-15GlyCylic15 mL in 1 BOTTLELIQUID155

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49406-00949406-009-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlyCylicSALICYLIC ACIDThe Tetra Corporation501d3ba9-ba42-4c1c-983b-492adaee039d2025-08-18WarningsExact identifier
ndc (package): 49406-009-15
ndc (product): 49406-009
ndc11 (package): 49406000915
spl id: 3ca9f427-1896-790a-e063-6394a90a980a
spl set id: 501d3ba9-ba42-4c1c-983b-492adaee039d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.